CATALOGO DEI PRODOTTI DELLA RICERCA

MELOTTI, Paola Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.685
EU - Europa 2.525
AS - Asia 1.285
SA - Sud America 9
OC - Oceania 8
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.522
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.657
GB - Regno Unito 1.042
CN - Cina 892
IT - Italia 294
SE - Svezia 273
IE - Irlanda 201
FR - Francia 187
SG - Singapore 161
RU - Federazione Russa 152
FI - Finlandia 132
DE - Germania 128
VN - Vietnam 91
UA - Ucraina 39
KR - Corea 38
TR - Turchia 35
BE - Belgio 27
CA - Canada 23
JP - Giappone 19
AT - Austria 14
HK - Hong Kong 11
NL - Olanda 11
IR - Iran 10
PL - Polonia 8
IN - India 6
AU - Australia 5
TG - Togo 5
BR - Brasile 4
ES - Italia 4
IL - Israele 4
VE - Venezuela 4
JO - Giordania 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
MX - Messico 2
PH - Filippine 2
PK - Pakistan 2
PT - Portogallo 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
JM - Giamaica 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 6.522
Salva come PNG Salva come JPEG
Città #
Southend 964
Chandler 585
Jacksonville 291
Woodbridge 289
Ann Arbor 220
Dublin 198
Verona 154
Ashburn 149
Beijing 149
Houston 143
Singapore 107
New York 94
Jinan 91
Wilmington 83
Lawrence 72
Princeton 72
Nanjing 71
Shenyang 68
Dong Ket 61
Hebei 35
Helsinki 35
Tianjin 34
Nanchang 33
Seoul 32
Ningbo 31
Haikou 29
Brussels 26
Changsha 25
Lancaster 25
Zhengzhou 25
Guangzhou 24
Jiaxing 24
Hangzhou 23
Sindelfingen 23
Taiyuan 23
Taizhou 23
Milan 19
Fairfield 18
Falls Church 17
Boardman 16
Tokyo 16
Seattle 15
Vienna 13
Elora 12
Dallas 11
Hong Kong 11
Los Angeles 11
Kent 10
Norwalk 10
Redwood City 10
Washington 10
Bologna 9
Redmond 9
San Francisco 9
Toronto 9
Dongguan 8
Lanzhou 7
Riva del Garda 7
Auburn Hills 6
Augusta 5
Lomé 5
San Mateo 5
Woodland 5
Amsterdam 4
Cambridge 4
Clearwater 4
Lappeenranta 4
London 4
Maracaibo 4
Rome 4
Villafranca di Verona 4
Warsaw 4
Yicheng 4
Amman 3
Fremont 3
Fuzhou 3
Groningen 3
Incheon 3
Isola della Scala 3
Kemerovo 3
Leawood 3
Novokuznetsk 3
Palermo 3
Riva 3
San Diego 3
Turin 3
Almere Stad 2
Andover 2
Ardabil 2
Canberra 2
Catanzaro 2
Changle 2
Chaoyang 2
Chicago 2
Civitavecchia 2
Dearborn 2
Düsseldorf 2
Edinburgh 2
Giv‘atayim 2
Henderson 2
Totale 4.721
Salva come PNG Salva come JPEG
Nome #
Development of FT-IR microspectroscopy for pre-clinical and clinical applications 177
Functional Evaluation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in human monocytes 134
Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis. 133
Analysis of CFTR function in human monocytes 129
Detection of CFTR protein in human leukocytes by flow cytometry. 127
Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) -T1 expression and activity in CF airway epithelial cells. 121
Analysis of proteins released from Pseudomonas aeruginosa clinical and laboratory strains: effects of azithromycin 114
Azithromicin decreases elevated glutathione-S-transferase T1 (GSTT1) and M1 (GSTM1) expression and activity in cystic fibrosis airways epithelial cells 114
Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) - T1 expression and activity in CF airway epithelial cells 114
WS18.3 A combination of CFTR functional tests supporting drug development and diagnosis: the contribution of intestinal epithelial organoids 112
MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects 110
Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis. 110
Analysis of Pseudomonas Aeuginosa secretome: consequences of oxygen limitation in clinical and laboratory strains 106
Combining standardized and new CFTR functional tests for diagnosis 106
Virulence and antibiotic resistance of Achromobacter spp. isolates from chronic and occasional lung infection in cystic fibrosis patients 105
Impaired CFTR function in mild cystic fibrosis associated with the S977F/T5TG12complex allele in trans with F508del mutation. 104
IMPAIRED CFTR FUNCTION IN MILD CF ASSOCIATED WITH THE S977F/T5TG12 COMPLEX ALLELE 104
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice 104
Impaired CTFR function in mild CF associated with the S977F/T5TG12 complex allele. 103
14 Standardized protocol for ratiometric measurement of b-adrenergic/cholinergic sweating in human sweat glands 102
Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency. 102
Poster Session Abstracts 101
Effects of high altitude on eosinophil protein X (EPX) serum levels and specific IgE for pteronyssinus (Dpt) and farinae (Df) in asthmatic children 99
Proteins released from Pseudomonas aeruginosa (Pa) referent and clinical strains under microaerobiosis and their effects on cystic fibrosis airways 99
Eosinophil activation in bronchial asthma: the role of adhesion molecules (ß1 and ß2 integrins) 98
An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests. 97
ePS01.7 Supporting diagnosis with a combination of standardized and new CFTR functional tests 97
DEVELOPMENT OF A CF, IL-8 TRANSGENIC MOUSE MODEL FOR THE IN VIVO LONG-TERM MONITORING OF LUNG INFLAMMATION 94
New potential biomarkers for the management of cystic fibrosis: measurements of CFTR expression & function in human leukocytes. 93
New clinical diagnostic procedures for cystic fibrosis in Europe. 92
Intestinal epithelial organoids contribute to combination of CFTR functional tests supporting drug development and diagnosis 92
Protein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors 92
AZITHROMYCIN EFFECT ON LUNG INFLAMMATION INDUCED BY PSEUDOMONAS AERUGINOSA RELEASED PROTEASES AS SHOWN BY IN VIVO IMAGING IN IL-8 TRANSIENTLY TRANSGENIZED MICE 92
Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN). 91
Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells 91
Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts 90
P139 Hypermutation as an evolutionary mechanism for Achromobacter spp. in cystic fibrosis lung infection 90
Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease. 89
20 In vivo monitoring of lung inflammation in CFTR–/– mice 88
null 84
In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin 83
In vivo monitoring of lung inflammation in CFTR-deficient mice 83
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses 82
Ratiometric sweat secretion optical test in cystic fibrosis, carriers and healthy subjects 81
22 Testing flow cytometry to detect CFTR expression recovery after drug treatment in epithelial cell lines 80
IMPACT OF POLYMORPHIC-794 CATT REPEATS OF MACROPHAGE MIGRATION INHIBITORY FACTOR PROMOTER ON SEVERITY OF CF 79
Poster Session Abstracts 79
HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients 78
Poster Session Abstracts 78
MOLECULAR IMAGING OF THE ANTI-INFLAMMATORY EFFECTS OF AZITHROMYCIN IN THE LUNG 77
Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium 76
Poster Session Abstracts 74
PROTEOMIC ANALYSIS OF PROTEINS RELEASED FROM PSEUDOMONAS AERUGINOSA CLINICAL AND LABORATORY STRAINS: EFFECTS OF AZITHROMYCIN 72
The identification of cystic fibrosis (CF) cells and their pharmacological correction by mid-infrared microspectroscopy and unsupervised data analysis methods 71
Receptor Protein Tyrosine Phosphatase gamma (Ptpg) regulates hematopoietic differentiation 70
RELEVANCE OF HLA-G IN CF 70
Oxidative stress and antioxidant therapy in cystic fibrosis 68
Toothbrushes may convey bacteria to the cystic fibrosis lower airways 66
STANDARDIZATION OF RATIOMETRIC MEASUREMENT OF BETA ADRENERGIC/CHOLINERGIC SWEATING IN HUMAN SWEAT GLANDS 64
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 64
Cystic fibrosis transmembrane conductance regulator functional evaluations in a G542X+/- IVS8Tn:T7/9 patient with acute recurrent pancreatitis 63
The role of macrophages and their scavenger receptors in cystic fibrosis 62
Relevance of oxygen limitation on pseudomonas aeruginosa strains: Effects on released proteins expression 62
Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients 61
PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients 60
Mobilome analysis of Achromobacter spp. isolates from chronic and occasional lung infection in cystic fibrosis patients 60
Optical Measurements of Sweat for in Vivo Quantification of CFTR Function in Individual Sweat Glands 60
Longitudinal monitoring of sinonasal and oral bacterial reservoirs to prevent chronic lung infection in people with cystic fibrosis 59
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 55
Identification of Potential Leukocyte Biomarkers Related to Drug Recovery of CFTR: Clinical Applications in Cystic Fibrosis 52
Achromobacter spp. adaptation in cystic fibrosis infection and candidate biomarkers of antimicrobial resistance 47
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: the international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF). 39
Impact of the polymorphic variant 5 FR/G-260C in the Multidrug Resistance-associate Protein-1 gene on severity of cystic fibrosis 37
Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast 36
CFTR Modulators Rescue the Activity of CFTR in Colonoids Expressing the Complex Allele p.[R74W;V201M;D1270N]/dele22_24 30
CFTR function is impaired in a subset of patients with pancreatitis carrying rare CFTR variants 27
Real-Life Experience with CFTR Modulators Shows Correction of LAD-IV Phenotype in Cystic Fibrosis 26
In Vivo Inflammation Caused by Achromobacter spp. Cystic Fibrosis Clinical Isolates Exhibiting Different Pathogenic Characteristics 25
Theratyping of the Rare CFTR Variants E193K and R334W in Rectal Organoid-Derived Epithelial Monolayers 25
Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis 23
In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells 17
null 16
Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination 2
Totale 6.639
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.735
article - articoli 12.158
book - libri 0
conference - conferenze 11.577
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.470
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020540 0 0 0 46 65 62 93 36 22 73 59 84
2020/2021718 92 133 37 90 63 49 15 31 25 2 81 100
2021/2022744 88 241 4 43 45 19 8 28 27 28 52 161
2022/20231.487 115 176 110 268 117 362 17 81 174 8 40 19
2023/2024842 53 57 51 82 79 161 33 62 38 45 128 53
2024/2025405 99 127 82 97 0 0 0 0 0 0 0 0
Totale 6.639